IPSC vs RTX · rev $6.6M vs P/E 36, rev $88.60B
Century Therapeutics Inc (IPSC) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
IPSC currently screens at market cap $47.8M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the IPSC and RTX stock pages for the full models.
Not investment advice.